Metraipolis › archive › dc_288c56803ddc

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study — Europe PMC PMID:41012570

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012570
DOI
10.3390/pharmaceutics17091235
License (as archived)
solo-consultazione
Archived
2026-11-09T20:06:16.775Z
SHA-256 of the archived text
576b324c15743548113605e255f422234aa1087cf0df85fd0cdac1f59a5bf43c
Stable URL of this page
https://metraipolis.com/documento/dc_288c56803ddc

How to cite

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study — Europe PMC PMID:41012570 — Europe PMC (en), https://europepmc.org/article/MED/41012570 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_288c56803ddc (Metraipolis archive dc_288c56803ddc, sha256 576b324c15743548113605e255f422234aa1087cf0df85fd0cdac1f59a5bf43c)
BibTeX
@misc{dc288c56803ddc,
  title = {Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study — Europe PMC PMID:41012570},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012570},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_288c56803ddc; sha256 576b324c15743548113605e255f422234aa1087cf0df85fd0cdac1f59a5bf43c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012570. Agents can read the archived copy with the MCP tool read_document.